Skip to main content
. 2020 Mar 5;136(5):572–584. doi: 10.1182/blood.2019002385

Table 1.

Characteristics of patient samples

Total (n = 213)
Median age (range; n = 189) 64 (31-84)
Male (%) 160/211 (76)
Performance status >1 (%) 35/176 (20)
Blastoid (%) 20/212 (9)
MIPI (%)
 Low 59/138 (43)
 Intermediate 34/138 (25)
 High 45/138 (33)
Treatment
 R-CHOP 147
 Observation 39
 Other 5
 Unknown 22
HSCT/AUTO 14

MCL tumor samples from 213 patients were obtained from patients living in British Columbia.

MIPI, MCL International Prognostic Index.